Screener
Exelixis EXEL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Exelixis’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares issued | — | — |
| Common stock, $0.001 par value; 400,000 shares authorized; issued and outstanding: 248,885 and 262,483 at June 30, 2026, and December 31, 2025, respectively | 249 | 262 |
| Additional paid-in-capital | 2,108,059 | 2,234,411 |
| Accumulated other comprehensive income (loss) | (2,013) | 3,476 |
| Accumulated deficit | (262,533) | (76,830) |
| Total stockholders’ equity | 1,843,762 | 2,161,319 |
Item 1. Financial Statements.
FAQ
- What is Exelixis's common stock?
- Exelixis (EXEL) reported common stock of 400M in Q2 2026.
- How has Exelixis's common stock changed year-over-year?
- Exelixis's common stock decreased by 0.0% year-over-year, from 400M to 400M.
- What is the long-term trend for Exelixis's common stock?
- Over 5 years (2020 to 2025), Exelixis's common stock has grown at a 318.4% compound annual growth rate (CAGR), from 312K to 400M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Exelixis's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude